A Study to Investigate the Preventive Effect of AG-1749 Against the Recurrence of Gastric and Duodenal Ulcers During Long-Term Treatment With Nonsteroid Anti-Inflammatory Drug.
Phase of Trial: Phase III
Latest Information Update: 03 Jun 2016
At a glance
- Drugs Lansoprazole (Primary) ; Gefarnate
- Indications NSAID-induced ulcer
- Focus Therapeutic Use
- Sponsors Takeda Pharma
- 08 Jul 2009 Actual number of patients (366) added as reported by ClinicalTrials.gov.
- 08 Jul 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 08 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.